Catalyst Pharm Inc (CPRX) Stock Price, Quote & News

Company Profile

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well...

Industry: Biotechnology

Sector: Healthcare

Phone: 305 420 3200

Website: catalystpharma.com

Address:

355 Alhambra Circle, Suite 801, Coral Gables, United States

WB_Bull Jul. 27 at 8:36 AM

$CPRX Thanks to everyone for all that professional comments. I was 14 years on that message board. My Investment is now in Santhera (SANN.SW), could be a next takeover (Owner of the Agamree Licence) . GLTA

0 · Reply

CH_Expat Jul. 22 at 1:55 PM

$CPRX @DLAT94 Anorher one I sold way too early. But the pick was good. Congrats longs!

1 · Reply

DeMontoire Jul. 17 at 10:52 PM

$CPRX we all were looking for this outcome. Been with this group for the better part of the last 10 years plus. I tank you all and I am super happy that many longs got to enjoy now the fruits of patience CPRX gave us. A good friend of mine worked at CPRX and introduced me to it when it was below $1. I can only thank him. So long all!

0 · Reply

nursetrader Jul. 16 at 1:12 AM

$CPRX thank you cprx management I got in around $3 and never looked back. Wonderful company run beautifully we had many tough times and scary moments but you guys made it through and brought us here. I wish every investment could be as perfect as what you guys have done here. I will miss y’all. ❤️

0 · Reply

Splashavelle Jul. 15 at 9:25 PM

$CPRX ty CPRX I tried to look at this account on Robinhood yesterday and it was gone but I had money in my account. Try powder for crypto. Sad and happy at the same time

0 · Reply

ElissaL Jul. 15 at 2:57 PM

$CPRX Now that the SEC today issued its official notice that Catalyst has been removed from the NASDAQ Exchange, I do not know how much longer this community will remain in existence here. So, I want to say that I will miss this group and the engaging posts that have occurred through the many years I have been a shareholder and participant here. I wish the very best to each and every one of you as shareholders and in your personal lives. It has been my pleasure to get to know many of you here and outside of this group. Take care everyone.

3 · Reply

FiduciaryPrinciples Jul. 15 at 1:46 PM

$CPRX Well I guess this is it. Congrats longs I hope to see almost all of you in another stock. Where are you all putting your money these days? Best of luck to you all.

3 · Reply

Splashavelle Jul. 15 at 6:29 AM

$CPRX what happened I don't see us on rh

0 · Reply

StocktwitsNews Jul. 10 at 12:02 AM

SEI Stock Jumps 5% After-Hours As S&P 600 Inclusion Sparks Buying $SEI $CPRX https://stocktwits.com/news/equity/markets/sei-stock-jumps-after-hours-as-sandp-600-inclusions-sparks-buying/cZmAZYNR7Fc

0 · Reply

pcstock12 Jul. 9 at 2:43 PM

$CPRX when the buyout will happen?

1 · Reply

Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst

Jul 16, 2026, 3:36 AM EDT - 19 days ago

Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals

Jul 8, 2026, 9:00 AM EDT - 26 days ago

Catalyst Pharmaceuticals Transcript: EGM 2026

Jun 30, 2026, 8:03 AM EDT - 4 weeks ago

Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses

Jun 30, 2026, 8:00 AM EDT - 4 weeks ago

Catalyst Pharmaceuticals Proxy statement: Proxy filing

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Catalyst Pharmaceuticals Proxy statement: Proxy filing

May 28, 2026, 8:00 AM EDT - 2 months ago

Catalyst Pharmaceuticals Proxy statement: Proxy filing

May 12, 2026, 8:00 AM EDT - 2 months ago

Catalyst Pharmaceuticals Proxy statement: Proxy filing

May 11, 2026, 4:12 PM EDT - 3 months ago

Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results

May 11, 2026, 4:00 PM EDT - 3 months ago

Catalyst Pharmaceuticals Quarterly report: Q1 2026

May 11, 2026, 4:00 PM EDT - 3 months ago

Catalyst Pharmaceuticals Earnings release: Q1 2026

May 8, 2026, 8:00 AM EDT - 3 months ago

Catalyst Pharmaceuticals Proxy statement: Proxy filing

May 7, 2026, 4:02 PM EDT - 3 months ago

Catalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast

May 7, 2026, 8:00 AM EDT - 3 months ago

Catalyst Pharmaceuticals Proxy statement: Proxy filing

May 7, 2026, 8:00 AM EDT - 3 months ago

Catalyst Pharmaceuticals Proxy statement: Proxy filing

May 7, 2026, 3:15 AM EDT - 3 months ago

Catalyst Pharma to Be Acquired by Angelini Pharma in $4.1 Billion Deal

May 7, 2026, 2:44 AM EDT - 3 months ago

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.

May 7, 2026, 2:24 AM EDT - 3 months ago

Italy's Angelini Pharma to buy Catalyst Pharmaceuticals for $4.1 billion

May 7, 2026, 2:14 AM EDT - 3 months ago

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease

Apr 28, 2026, 8:03 AM EDT - 3 months ago

Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026

Apr 15, 2026, 7:33 AM EDT - 3 months ago

See How Institutions Boost Catalyst Shares

Mar 10, 2026, 3:30 PM EDT - 5 months ago

Catalyst Pharmaceuticals Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 6, 2026, 8:03 AM EST - 5 months ago

Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference

Feb 26, 2026, 8:30 AM EST - 5 months ago

Catalyst Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 5 months ago

Catalyst Pharmaceuticals Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 5 months ago

Catalyst Pharmaceuticals Annual report: Q4 2025

Feb 25, 2026, 4:07 PM EST - 5 months ago

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance

Feb 24, 2026, 8:03 AM EST - 5 months ago

Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference

Feb 11, 2026, 8:03 AM EST - 6 months ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026

Jan 12, 2026, 6:45 PM EST - 7 months ago

Catalyst Pharmaceuticals Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 7:00 AM EST - 7 months ago

Catalyst Pharmaceuticals Slides: Corporate presentation

Jan 8, 2026, 8:03 AM EST - 7 months ago

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies

Dec 15, 2025, 8:03 AM EST - 8 months ago

Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 8, 2025, 12:35 PM EST - 8 months ago

Catalyst Pharmaceuticals Transcript: BofA Securities CNS Therapeutics Virtual Conference 2025

Dec 2, 2025, 1:00 PM EST - 8 months ago

Catalyst Pharmaceuticals Transcript: Citi Annual Global Healthcare Conference 2025

Nov 24, 2025, 8:03 AM EST - 9 months ago

Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

Nov 19, 2025, 8:03 AM EST - 9 months ago

Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™

Nov 18, 2025, 8:03 AM EST - 9 months ago

Catalyst Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference

Nov 17, 2025, 9:00 AM EST - 9 months ago

Catalyst Pharmaceuticals Transcript: Jefferies London Healthcare Conference 2025

Nov 6, 2025, 8:30 AM EST - 9 months ago

Catalyst Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 9 months ago

Catalyst Pharmaceuticals Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 9 months ago

Catalyst Pharmaceuticals Quarterly report: Q3 2025

Nov 5, 2025, 4:06 PM EST - 9 months ago

Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 4, 2025, 4:03 PM EST - 9 months ago

Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work

Nov 3, 2025, 8:03 AM EST - 9 months ago

Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference

Oct 22, 2025, 8:03 AM EDT - 10 months ago

Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025

Oct 9, 2025, 8:03 AM EDT - 10 months ago

Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences

Oct 1, 2025, 8:03 AM EDT - 10 months ago

Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program

Sep 9, 2025, 12:50 PM EDT - 11 months ago

Catalyst Pharmaceuticals Transcript: Baird Global Healthcare Conference 2025

Sep 8, 2025, 9:00 AM EDT - 11 months ago

Catalyst Pharmaceuticals Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 3:20 PM EDT - 11 months ago

Catalyst Pharmaceuticals Transcript: Cantor Global Healthcare Conference 2025

Sep 3, 2025, 2:15 PM EDT - 11 months ago

Catalyst Pharmaceuticals Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 28, 2025, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

Aug 26, 2025, 7:12 PM EDT - 1 year ago

UPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

Aug 25, 2025, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

Aug 7, 2025, 8:30 AM EDT - 1 year ago

Catalyst Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 1 year ago

Catalyst Pharmaceuticals Earnings release: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 1 year ago

Catalyst Pharmaceuticals Quarterly report: Q2 2025

Aug 6, 2025, 4:13 PM EDT - 1 year ago

Catalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update

Aug 6, 2025, 8:03 AM EDT - 1 year ago

Lambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC)

Aug 4, 2025, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors

Jul 22, 2025, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025

Jun 11, 2025, 7:08 AM EDT - 1 year ago

Strong Inflows Make Catalyst Stock an Outlier

Jun 11, 2025, 7:00 AM EDT - 1 year ago

20 stocks you should avoid — no matter how well the market does

CORT CRK CRNC DDD LUMN LYV MGPI

Jun 2, 2025, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer

May 14, 2025, 11:00 AM EDT - 1 year ago

Catalyst Pharmaceuticals Transcript: Bank of America 2025 Healthcare Conference

May 12, 2025, 2:00 AM EDT - 1 year ago

Catalyst Pharmaceuticals Slides: Corporate Presentation

May 8, 2025, 8:30 AM EDT - 1 year ago

Catalyst Pharmaceuticals Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Catalyst Pharmaceuticals Earnings release: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Catalyst Pharmaceuticals Quarterly report: Q1 2025

May 7, 2025, 4:14 PM EDT - 1 year ago

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

Apr 30, 2025, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

Apr 22, 2025, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Catalyst Pharmaceuticals Proxy statement: Proxy Filing

Apr 8, 2025, 8:06 AM EDT - 1 year ago

Catalyst Pharmaceuticals Announces Health Canada's Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals

Mar 26, 2025, 8:12 AM EDT - 1 year ago

Strong Revenue, Drug Performance Lift Catalyst Shares

Mar 11, 2025, 1:00 PM EDT - 1 year ago

Catalyst Pharmaceuticals Transcript: Barclays 27th Annual Global Healthcare Conference

Mar 4, 2025, 8:03 AM EST - 1 year ago

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference

Feb 27, 2025, 8:30 AM EST - 1 year ago

Catalyst Pharmaceuticals Earnings Call Transcript: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

Catalyst Pharmaceuticals Earnings release: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

Catalyst Pharmaceuticals Annual report: Q4 2024

Feb 26, 2025, 4:13 PM EST - 1 year ago

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 12, 2025, 8:03 AM EST - 1 year ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

Feb 7, 2025, 3:56 PM EST - 1 year ago

Catalyst Remains a Big Money Favorite

Jan 23, 2025, 8:03 AM EST - 1 year ago

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

Jan 21, 2025, 8:19 AM EST - 1 year ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan

WB_Bull Jul. 27 at 8:36 AM

0 · Reply

CH_Expat Jul. 22 at 1:55 PM

$CPRX @DLAT94 Anorher one I sold way too early. But the pick was good. Congrats longs!

1 · Reply

DeMontoire Jul. 17 at 10:52 PM

0 · Reply

nursetrader Jul. 16 at 1:12 AM

0 · Reply

Splashavelle Jul. 15 at 9:25 PM

$CPRX ty CPRX I tried to look at this account on Robinhood yesterday and it was gone but I had money in my account. Try powder for crypto. Sad and happy at the same time

0 · Reply

ElissaL Jul. 15 at 2:57 PM

3 · Reply

FiduciaryPrinciples Jul. 15 at 1:46 PM

$CPRX Well I guess this is it. Congrats longs I hope to see almost all of you in another stock. Where are you all putting your money these days? Best of luck to you all.

3 · Reply

Splashavelle Jul. 15 at 6:29 AM

$CPRX what happened I don't see us on rh

0 · Reply

StocktwitsNews Jul. 10 at 12:02 AM

SEI Stock Jumps 5% After-Hours As S&P 600 Inclusion Sparks Buying $SEI $CPRX https://stocktwits.com/news/equity/markets/sei-stock-jumps-after-hours-as-sandp-600-inclusions-sparks-buying/cZmAZYNR7Fc

0 · Reply

pcstock12 Jul. 9 at 2:43 PM

$CPRX when the buyout will happen?

1 · Reply

Mergerbrief Jul. 8 at 11:55 AM

$CPRX / Angelini Pharma – Shareholder Vote $CPRX

0 · Reply

STONER_Smurf Jul. 6 at 11:41 PM

$CPRX this keeps heading higher and higher. Fuck I never got in at when it was sub 10 LOL I wished you boys good luck a few times over the last couple years and it keep going. Congrats , nice steady as she goes

1 · Reply

pcstock12 Jun. 20 at 12:43 AM

$CPRX did anyone receive anything about the virtual meeting to vote on the merger?

0 · Reply

pcstock12 Jun. 20 at 12:39 AM

$CPRX https://www.stocktitan.net/sec-filings/CPRX/defm14a-catalyst-pharmaceuticals-inc-merger-proxy-statement-91233ea639e8.html

0 · Reply

BioTechHealthX Jun. 14 at 4:08 PM

$CPRX Catalyst Pharmaceuticals (CPRX) may not be the wildest biotech name on Wall Street, but that may be its biggest advantage. With profits, revenue, and rare disease exposure, this small-cap healthcare stock offers a more stable twist on biotech investing. https://biotechhealthx.com/biotech-news/is-catalyst-pharmaceuticals-cprx-a-smart-rare-disease-stock-to-buy-for-long-term-growth/

0 · Reply

Jjuicy8 Jun. 13 at 2:31 AM

$CPRX I bought 53 at 2.40 in 2018, should I sell now??

1 · Reply

BioTechHealthX Jun. 12 at 9:49 AM

$ARQT $AUPH $CPRX $OCUL $TRVI From cancer cell therapy to rare disease treatments and eye-disease breakthroughs, these small-cap biotech stocks are chasing major medical markets. Here are 10 biotech companies drawing attention for their pipelines, revenue growth, and upside potential. https://biotechhealthx.com/biotech-news/top-5-small-cap-biotech-stocks-that-could-surge-100/

0 · Reply

BigGainTom Jun. 11 at 2:52 PM

$CPRX Is this company sold? Why such low amplitude of stock movements?

1 · Reply

StillWaiting101 Jun. 5 at 8:04 PM

$CPRX I miss the stability we had here, its scary out there right now lol

1 · Reply

DeMontoire Jun. 3 at 12:15 PM

$CPRX is there a point on keeping any shares invested and wait for the closing in 6 months?

0 · Reply

pcstock12 May. 30 at 5:08 PM

$CPRX any update on shareholders votes on the buyout?

1 · Reply

beachlife May. 28 at 10:55 PM

$CPRX can’t believe I went all in at 32.55. I can’t time nothing right🤪

0 · Reply

Market Cap	3.86B
Revenue (ttm)	588.99M
Net Income (ttm)	214.33M
EPS (ttm)	N/A
PE Ratio	11.92
Forward PE	11.93
Profit Margin	36.39%
Debt to Equity Ratio	0.00

Volume	15,513,800
Avg Vol	2,707,952
Day's Range	N/A - N/A
Shares Out	122.42M
Stochastic %K	80%
Beta	0.74
Analysts	Sell
Price Target	$32.80